TLR9 -1486C/T polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation.

MLA

de la Fuente, Sara, et al. “TLR9 -1486C/T Polymorphism Is Associated with Hepatocellular Carcinoma Recurrence after Liver Transplantation.” Biomarkers in Medicine, vol. 13, no. 12, Aug. 2019, pp. 995–1004. EBSCOhost, https://doi.org/10.2217/bmm-2019-0030.

APA

de la Fuente, S., Citores, M.-J., Lucena, J.-L., Muñoz, P., & Cuervas-Mons, V. (2019). TLR9 -1486C/T polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation. Biomarkers in Medicine, 13(12), 995–1004. https://doi.org/10.2217/bmm-2019-0030

Chicago

de la Fuente, Sara, María-Jesús Citores, José-Luis Lucena, Pablo Muñoz, and Valentín Cuervas-Mons. 2019. “TLR9 -1486C/T Polymorphism Is Associated with Hepatocellular Carcinoma Recurrence after Liver Transplantation.” Biomarkers in Medicine 13 (12): 995–1004. doi:10.2217/bmm-2019-0030.